PTGX NASDAQ
Protagonist Therapeutics, Inc.
1W: -1.3%
1M: -4.1%
3M: +6.5%
YTD: +60.7%
1Y: +118.8%
3Y: +697.1%
5Y: +644.6%
$140.06
+0.87 (+0.63%)
Weekly Expected Move ±3.7%
$130
$135
$140
$145
$151
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$282M
Revenue
+34.8% YoY
$83M
Net Income
+59.3% YoY
$132M
Free Cash Flow
+256.3% YoY
100.0%
Gross Margin
74.4%
Op. Margin
76.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE11.0%
ROA10.3%
ROIC84.1%
Valuation
P/E115.0
P/B11.0
EV/EBITDA92.8
Leverage
Debt/Equity0.01
Current Ratio21.71
Interest Cov.0.0x
Quality Scores
Piotroski F7/9
Altman Z119.88
Beneish M29.86